Status:
COMPLETED
Communication in Breast Cancer Care
Lead Sponsor:
Leiden University
Collaborating Sponsors:
Dutch Cancer Society
The Netherlands Cancer Institute
Conditions:
Communication
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The investigators will create 4 information-video's about chemotherapy side-effects in curative breast cancer care. The communication is manipulated in the four videos. Participants will watch the vid...
Detailed Description
NA, the investigators cannot yet reveal the manipulation as it would influence the participants.
Eligibility Criteria
Inclusion
- Adult (\>18 years old) female breast cancer patients
- Chemo-naïve patients
- Scheduled in for curative neo-adjuvant chemotherapy: Four courses of AC chemotherapy (all combinations of AC + other chemotherapy courses are eligible)
- Cognitively able to fill out an online questionnaire
- Having internet access
- Sufficient command of the Dutch language
- pre-chemo no previous treatment or pre-chemo breast-conserving surgery and radiotherapy (WLE patients)
Exclusion
- NA
Key Trial Info
Start Date :
June 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT05390723
Start Date
June 5 2022
End Date
September 1 2023
Last Update
December 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antoni van Leeuwenhoek
Amsterdam, North Holland, Netherlands, 1066CX